AstraZeneca Announces Enhertu Approved in China for HER2
AstraZeneca’s Breakthrough Lung Cancer Treatment Expands Options for Chinese Patients The announcement of Enhertu being approved in China is an ...
Tag: HER2-mutant NSCLC therapy